Azelis Group

Specialty Chemicals Will Endure Market Headwinds With Gradual Relief

AnalystLowTarget

Not Invested

Consensus Narrative from 14 Analysts

Published

30 Jun 25

AnalystLowTarget's Fair Value

€16.00

23.9% undervalued

10 Sep

€12.18

-38.4%

-1.9%

-38.4%

-1.9%

Edit anytime before Jun 30 10:16 PM. Then post Updates to your followers.

Author's Valuation

€16.0

23.9% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

€16

23.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.76%

Trade Distributors revenue growth rate

0.31%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

9.09%

Calculation

€219.87m

Earnings '28

22.90x

PE Ratio '28

€5.04b

Market Cap '28

€5.04b

Market Cap '28

243.64m

No. shares '28

€20.67

Share Price '28

€20.67 Share Price '28

Discounted to 2025 @ 9.01% p.a.

€15.96

Fair Value '25